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Abstract  
 
Background: Aortic stenosis shares some ethiopathological features with atherosclerosis 
and increasing evidence links Toll-like receptors (TLRs) to atherogenesis. 
Methods: TLR-mediated inflammation and osteogenesis were investigated in human 
interstitial cells isolated from stenotic and non-stenotic aortic valves. TLR expression 
and signalling were evaluated by quantitative RT-PCR, flow cytometry, Western blot 
analysis, ELISA, and cytokine arrays. Osteogenesis was evaluated by measuring 
alkaline phosphatase activity.  
Results: Interstitial cells from control valves express most TLRs, being TLR4 the most 
abundant, whereas cells from stenotic valves express higher TLR4 and TLR2 and lower 
TLR5 and TLR9 transcript levels. When pro-inflammatory pathways were analyzed, we 
observed that TLR4, TLR2 and TLR3 ligands induced an early activation of NF-κB and 
p38 MAPK activation in cells from control and stenotic valves. Strikingly, when TLRs 
sensing viral patterns were studied, a sustained TLR3-mediated activation of NF-κB, a 
κB-independent induction of catalytically active cyclooxigenase (COX)-2 and ICAM-1 
expression, and induction of expression of several chemokines were observed. TLR4, 
but not TLR2, engagement produced a similar but NF-κB-dependent effect. Moreover, 
TLR3 and TLR4 agonists induced alkaline phosphatase expression and activity.  
Conclusions: Exposure of aortic valve interstitial cells to viral and Gram-negative 
bacteria molecular patterns induces distinct and long-term TLR-mediated pro-
inflammatory and pro-osteogenic responses that might be relevant to the pathogenesis 
of degenerative aortic stenosis. 
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1. Introduction 
 
 Degenerative aortic stenosis, the most common cause of valve replacement in 
western countries, is a common disease in the elderly characterized by progressive 
calcification and increased valve thickness [1]. Valvular calcification is no longer 
considered a degenerative and passive process but an actively regulated process, the 
molecular mechanisms of which remain to be elucidated [1,2]. Many studies have 
shown the role of atherogenic risk factors in valve calcification. In fact aortic stenosis 
shares some ethiopathological features with the atherosclerosis, like inflammatory cell 
infiltration, oxidized lipid deposition, and cytokine expression, although there are some 
differentiating features [2,3]. At the molecular level, inflammatory mediators, growth 
factors, matrix metalloproteinases, the renin-angiotensin system, and pro-osteogenic 
pathways have been shown to participate in valve disease pathogenesis [1,2],
 
although a 
pharmacological target valuable for the development of therapies is still to be defined.  
Toll-like receptors (TLRs), key players in the innate and adaptive immunity, have 
been associated to the pathogenesis of inflammatory diseases such as atherosclerosis 
[4]. TLRs are a family of transmembrane receptors involved in the recognition of 
conserved patterns from microbes, as well as danger-associated endogenous molecules 
[5]. To date several TLRs, 11 in humans, have been identified [5]. Cell-surface 
receptors include TLR4 that recognizes lipopolysaccharide present in Gram-negative 
bacteria, TLR2 and its co-receptors TLR1/TLR6, which sense bacterial lipoproteins and 
lipoteichoic acid, TLR5 that recognizes bacterial flagellin, TLR11 that senses profiling-
like molecules in parasites, and TLR10, the ligand of which remains unknown. Another 
subtype of receptors localized in the endosomal cell compartment include TLR3, that 
recognizes dsRNA, TLR9, that senses unmethylated CpG motifs present in viral and 
5 
 
bacterial genome and parasites, and TLR7, that binds ssDNA [5]. Upon stimulation, 
TLRs initiate intracellular signalling cascades that ultimately promote pro-inflammatory 
gene expression. All TLRs, but TLR3, induce MyD88-dependent activation of NF- B 
and MAPK cascades, while a MyD88-independent pathway, involving the induction of 
IFN-inducible genes, have been described to be triggered upon TLR3 and TLR4 
activation [5]. Accumulating evidence links TLR activation to atherogenesis, especially 
TLR2 and TLR4, although new evidences support the involvement of viral receptors 
[4,6]. Even more, the TLR4-D299G human polymorphism has been associated to lower 
risk of carotid atherosclerosis and increased risk of myocardial infarction [6]. More 
recently, a clinical study demonstrated that high expression of TLR2 on monocytes is a 
risk factor for atherogenesis, independent from other established risk factors [7]. 
Cardiovascular cells such as cardiomyocytes, vascular smooth muscle and 
endothelial cells are known to express TLRs [8]. Moreover, aortic valve interstitial cells 
(AVICs), a prominent cell type in the heart valve leaflets that can undergo a phenotypic 
differentiation to osteoblast-like cells and play a role in valve calcification [9,10],
 
have 
been described to express TLR4 and TLR2 [11]. Given the connection between TLR 
and the atherosclerosis process, which shares some pathophysiological features with 
aortic stenosis, and to better understand the molecular mechanisms underlying the valve 
disease, we explored the role of TLR activation in human AVICs isolated from 
surgically explanted stenotic and non-stenotic aortic valves. For that purpose, we 
evaluated TLR expression in cells from control and calcified stenotic valves, as well as 
TLR-coupled signalling cascade, and induction of pro-inflammatory mediators and 
calcification markers.  
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2. Methods 
 
2.1. Reagents  
 
 Collagenase type II and M199 medium were from Invitrogen (Carlsbad, CA). Bovine 
fetal serum and antibiotics were from Clonetics-Lonza (Walkersville, MD). E. coli LPS, 
bis-benzimide (DAPI), alkaline phosphatase (ALP) blue kit, and an anti- -tubulin 
antibody were purchased from Sigma (St. Louis, MO). Pam3CSK4, CpG-ODN, and 
polyinosinic-polycytidylic acid (poly (I:C)) were from InvivoGen (San Diego, CA). 
Antibodies against ERK, cyclooxigenase (COX)-2, and intercellular adhesion molecule 
(ICAM)-1 were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-JNK, 
anti-phospho-p38, and anti-phospho-Ser 536-pNF- B p65 form antibodies were from 
Cell Signaling (Danvers, MA). Anti-phospho-ERK antibody was from Promega 
(Madison, WI). TRIzol was from Life Technologies (Grand Island, NY). PE-conjugated 
anti-human TLR4, IgG2a-PE isotype control, and goat anti-mouse IgG-FITC antibodies 
were from eBioscience (San Diego, CA). Enhanced chemiluminiscence detection 
system was from Pierce (Rockford, IL). NF-κB SN50 was from Calbiochem 
(Darmstadt, Germany). PGE2 immunoassay kit was from GE-Amersham 
(Buckinghamshire, United Kingdom). Cytokine antibody array V was from RayBiotech, 
Inc. (Norcross, GA). ALP Fluorometric Assay Kit was from Abcam (Cambridge, UK). 
 
2.2. Patient selection 
 
 The study included 10 explanted heart valves from patients with degenerative aortic 
stenosis and indication for valve replacement (6 males/4 females, mean age 72.0 ± 7.1 
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years). Aortic valve area was 0.7 ± 0.2 cm², peak gradient 88 ± 22 mmHg and mean 
gradient 56 ± 15 mmHg. Control group consisted of 10 aortic valves from transplanted 
patients with valve disease excluded by echocardiography (8 males/2 females, mean age 
59.3 ± 6.2 years). Diagnosis of the aortic valve lesion and indications for valve 
replacement and heart transplant was performed following European guidelines. All 
patients gave informed consent and Hospital Clínico Universitario Review Board 
approved the study, which complies with the Declaration of Helsinki. 
 
2.3. Isolation and culture of human AVICs  
 
 After surgery, the aortic valves were dissected to eliminate non-valvular tissue, and 
calcium deposits in the case of stenotic valves. Cells were isolated with a method based 
on sequential digestion of valve leaflets  with 2.5 mg/ml collagenase for 30 min at 37 
ºC, and 0.8 mg/ml collagenase for 3 h at 37 ºC [11]. Then, cells were cultured in M199 
media supplemented with penicillin G, streptomycin, amphotericin B and 10% serum. 
For the experiments, AVICs from passages 3-6 were used. Before performing 
experiments, cells were cultured in low-serum media (M199 supplemented with 
antibiotics and 2% serum). α-SM-actin staining [12] revealed no apparent 
morphological differences in cells explanted from control and stenotic valves and 
confirmed that more than 95% cells were myofibroblast-like (data not shown). For 
calcification experiments, cells were cultured in conditioning medium (M199 
supplemented with 10 mmol/l -glycerophosphate, 10 nmol/l vitamin D3, and 10 nmol/l 
dexamethasone) as previously described [13], and stimulated with TLR ligands or 
vehicle for 17-19 days. 
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2.4. Real-time RT-PCR analysis  
 
 RNA was isolated using TRIzol reagent and reverse transcription-PCR was 
performed using following sets of primers. TLR1 (sense 5´-
GGGTCAGCTGGACTTCAGAG-3´, anti-sense 5´-AAAATCCAAATGCAGGAACG-
3´); TLR2 (sense 5´-TCAGCCTCTCCAAGGAAGAA-3´, anti-sense 5´-
AATGTTCAAGACTGCCCAGG-3´); TLR3 (sense 5´-
AGCCTTCAACGACTGATGCT-3´, anti-sense 5´-TTTCCAGAGCCGTGCTAAGT-
3´); TLR4 (sense 5´-TGAGCAGTCGTGCTGGTATC-3´, anti-sense 5´-
CAGGGCTTTTCTGAGTCGTC-3); TLR5 (sense 5´-
GGAACCAGCTCCTAGCTCCT-3´, anti-sense 5´-AAGAGGGAAACCCCAGAGAA-
3´);  TLR6 (sense 5´-CCCTTTAGGATAGCCACTGC-3´, anti-sense 5´-
CTCACAATAGGATGGCAGGA-3´); TLR7 (sense 5´-
CCTTGAGGCCAACAACATCT-3´, anti-sense 5´-GTAGGGACGGCTGTGACATT-
3´); TLR8 (sense 5´-TCCTTCAGTCGTCAATGCTG-3´, anti-sense 5´-
CGTTTGGGGAACTTCCTGTA-3´); TLR9 (sense 5´-
GGACACTCCCAGCTCTGAAG-3´, and anti-sense 5´-TTG 
GCTGTGGATGTTGTTGT-3´). cDNA was amplified in a PTC-200 apparatus 
(BioRad) using SYBR Green I mix containing HotStart polymerase. -actin was used as 
a housekeeping gene to assess the relative abundance of mRNA. 
 
2.5. Flow cytometry analysis 
 
 TLR4 expression was analyzed by flow cytometry using cells permeabilized or not 
with 0.1% saponin prior to staining with PE-conjugated anti-TLR4 antibody (1:10 
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dilution in PBS, 2% serum, EDTA) for 30 min at 4 ºC. Positively stained cells were 
detected by comparison with the background fluorescence samples stained with a PE-
conjugated isotype-specific control antibody. Flow cytometry analysis was performed in 
a Beckman Coulter device (Epics XL-MCL). Data was analyzed using WinMDI 
software. 
 
2.6. Immunodetection of pNF-κB, MAP kinases, COX-2, and ICAM-1 
 
 TLR-activated cells were analyzed by Western blot as described earlier [14]. 
Briefly, cells were lysed with TNE buffer (20 mmol/L Tris-HCl, pH 7.4, 150 mmol/L 
NaCl, 5 mmol/L EDTA, 0.01% NP-40, and a cocktail of protease and phosphatase 
inhibitors) for 10 min on ice. 50 g protein per lane was analyzed, and proteins were 
visualized using a chemiluminescence detection system. NF- B activation was 
measured using an anti-phospho-NF- B p65 antibody. MAP kinase activation was 
evaluated using phosphospecific antibodies for the phosphorylated forms of ERK, 
JNK, and p38 MAPK. Expression of pro-inflammatory molecules was detected with 
human COX-2 and ICAM-1 antibodies. Equal loading across the gel was confirmed 
using an anti- -tubulin antibody.  
 
2.7. ELISA for human prostaglandin (PG)-E2 
 
 Supernatants from human AVICs stimulated with the corresponding TLR ligands 
for 8, 12 and 24 h were used to quantify PGE2 secretion by an immunoassay kit 
following the manufacturer´s protocol. Absorbance was measured using a microplate 
reader Versamax (Molecular Devices, Sunnyvale, CA).  
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2.8. Analysis of cytokine expression levels by protein arrays 
 
Supernatants from cells stimulated with corresponding ligand for 12 h at 37 ºC were 
analyzed with Human Cytokine Antibody Array V. Briefly, previously blocked 
membranes were incubated with supernatants for 2 h, later incubated with the primary 
biotin-conjugated antibody for 2 h, followed by incubation with HRP-conjugated 
streptavidin antibodies for 1 h. Chemiluminiscence detection was followed with 
exposure to x-ray film. Densitometry of cytokine spots was analyzed by Image Quant 
TL software (Amersham, Buckinghamshire, UK). 
 
2.9. ALP activity assay and staining 
 
 To evaluate ALP expression, cells were fixed with p-formaldehyde, stained with the 
ALP blue kit following manufacturer´s protocol, and photographed. For measuring 
ALP activity, cells were lysed with 20 mmol/L Tris-HCl, pH 8, 150 mmol/L NaCl, 
0.2% NP-40, and a cocktail of protease and phosphatase inhibitors, as previously 
described [13], the enzymatic activity was evaluated using a fluorometric assay kit, and 
results were expressed as pmol/min.h.  
 
2.10. Statistical analysis 
 
 Results are expressed as mean  SD. Data were analyzed by either unpaired t´ test 
using GraphPad Prism version 4 (San Diego, CA). Differences were considered 
statistically significant for a p < 0.05. 
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3. Results 
 
3.1. Human AVICs from control valves express most of TLRs 
 
 To evaluate TLR gene expression in human AVICs, we quantified the TLR mRNA 
levels by real time RT-PCR. Experiments performed with n= 10 valves revealed that all 
TLRs, but TLR8, are expressed in human AVICs, the TLR4 receptor being the most 
abundant subtype, with the others expressed at lower levels (Fig. 1A). Cells express 
receptors such as TLR2 and TLR4 (Fig. 1A), consistent with a recent report [11], as 
well as TLR2 co-receptors TLR1 and TLR6, and TLR5. Interestingly, cells also express 
endosomal receptors involved in sensing nucleic acids like TLR3, and to a lower extent 
TLR7 and TLR9 (Fig. 1A).  
 
3.2. Differential TLR mRNA expression in AVICs from stenotic and control valves 
 
 Next, we analyzed TLR gene expression in AVICs isolated from stenotic valves. 
Similar TLR expression profiles, but differences in transcript levels, were observed in 
AVICs from stenotic as compared to control valves (Fig. 1A). Quantitative analysis 
revealed an increase of TLR4 and TLR2 mRNA levels in stenotic as compared to 
control valves (TLR4: control 737.8 ± 122.9, stenotic 2163.0 ± 452.3; TLR2: control 
53.8 ± 9.5, stenotic 101.2 ± 22.1), while no significant differences on TLR2 co-
receptors TLR1 and TLR6 were observed. On the contrary, TLR5 levels were 
significantly diminished in stenotic valves (Fig. 1A). As for endosomal receptors, TLR9 
showed a significant lower expression in stenotic valves, while no statistically 
significant differences in TLR3 and TLR7 levels were observed in control and diseased 
valves (Fig. 1A). Together, data show over-expression of TLR4 and TLR2, and down-
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regulation of TLR5 and TLR9 in AVICs from stenotic valves when compared to those 
from control valves. 
 
3.3. Total cellular but not cell-surface TLR4 is higher in AVICS from stenotic valves 
than in control valves 
 
 To assess TLR4 protein expression, AVICs labelled with a fluorescent anti-TLR4 
antibody were analyzed by flow cytometry. In experiments performed with control 
AVICs permeabilized with saponin, a single peak of fluorescence was observed, while 
two peaks with low and higher fluorescence intensity were observed in non-
permeabilized cells (Fig. 1B), suggesting the existence of two populations of TLR4 and 
that most receptors are not expressed on the cell-surface but are internalized or have not 
yet located into the membrane. Likewise, AVICs from stenotic valves showed two 
distinct TLR4 populations (Fig. 1C). When comparing the relative expression, the total 
cellular TLR4 was significantly higher in AVICs from stenotic as compared to control 
valves (Fig. 1D) consistent with quantitative RT-PCR results, while no significant 
differences in the number of cell-surface receptors were observed. Together, results 
suggest that most of TLR4 are not exposed to the cell-surface, being the total cellular, 
and not cell-surface, increased in AVICs from stenotic as compared to control valves. 
 
3.4. TLR3, TLR2 and TLR4 agonists induce NF-κB and MAPK/p38 activation in AVICS 
from control and stenotic valves 
 
 Since TLR signalling promotes the activation of NF-κB and MAPK cascades [5], and 
AVICS express functional TLR2 and TLR4 [11],
 
we assessed intracellular signalling of 
13 
 
TLRs involved in the recognition of nucleic acids and compared with TLRs that sense 
bacterial patterns. For this purpose, cells were either stimulated with a TLR3 agonist, 
poly (I:C), a synthetic polymer of inosine that resembles the RNA of infectious viruses 
and stimulates the production of interferon, or a TLR9 agonist, CpG-ODN, an 
unmethylated sequence present in bacterial and viral DNA. In AVICs from control and 
stenotic valves, NF-κB p65 phosphorylation was observed after 20-60 min stimulation 
with poly (I:C) but not with CpG-ODN (Fig. 2, panels A-B), consistent with the low 
expression of TLR9 in AVICs (Fig. 1A). As for bacterial patterns, LPS and Pam3CSK4 
stimulation induced NF-κB p65 phosphorylation in control AVICs (Fig. 2A), and 
similar results were observed with cells from diseased valves (Fig. 2B). Next, we 
evaluated the activation of MAPK cascades by using phosphospecific antibodies. 
Interestingly, a phosphorylated form of MAPK/p38, a kinase with an important role on 
inflammation, was detected 20-60 min upon stimulation with TLR3, TLR4, and TLR2 
agonists (Fig. 2, panels A-B). We also evaluated the MAPK/ERK pathway, known to 
play a crucial role in osteoblast differentiation and mineralization [15],
 
by measuring 
ERK1/ERK2 phosphorylation. Interestingly, AVICs from control and stenotic valves 
showed some degree of ERK phosphorylation in basal conditions (Fig. 2, panels A-B); 
being ERK2 the major phosphorylated form. Likewise, the MAPK/JNK cascade was 
already activated in resting cells (Fig. 2, panels A-B); being JNK2 the major 
phosphorylated form in AVICs. Together, results show that TLR3, TLR2, and TLR4 
induce the activation of the NF-κB and MAPK/p38 pro-inflammatory pathways, in 
AVICs from both stenotic and non-stenotic valves. 
 
3.5. TLR3 activation promotes NF-κB-independent induction of pro-inflammatory 
molecules in AVICs from control and stenotic valves 
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 Next, we evaluated TLR signalling at late times and the induction of pro-
inflammatory molecules. Interestingly, poly (I:C), but not CpG, induced sustained NF-
κB activation, since a  phosphorylated form of NF-κB p65 was detected 12-24 h after 
stimulation of AVICs from control and stenotic valves (Fig. 3A). Strikingly, poly (I:C) 
strongly induced the expression of the pro-inflammatory enzyme COX-2 in AVICs 
from control valves and stenotic valves (Fig. 3A). Consistent with these results, PGE2, a 
major product of COX-2 activity, was detected in the supernatants of TLR3-activated 
AVICs from control and stenotic valves (Fig. 3, panels B-C). Later, we tested the 
expression of the adhesion molecule ICAM-1, previously described to be induced by 
LPS in AVICs [11].
 
TLR3-mediated induction of COX-2, PGE2 and ICAM-1 
expression was very robust and the kinetic showed a biphasic response (Fig. 3A). 
Moreover, the effect was not blocked by SN50, a NF-κB inhibitor that prevents NF-κB 
translocation into the nucleus (Fig. 3D), suggesting that NF-κB complexes containing 
p50 protein are not involved in the response, but a sequence initiated by TRIF/IRF3 
activation might play a role. These results suggest that AVICs exposed to agonists 
mimicking viral patterns activate TLR3-mediated and NF-κB-independent pro-
inflammatory responses.  
 
3.5. Engagement of TLR4, but not TLR2, induces NF-κB-dependent expression of pro-
inflammatory molecules in AVICs from control and stenotic valves 
 
 Next, we evaluated the induction of pro-inflammatory molecules by bacterial 
patterns. Notably, LPS-mediated NF-κB activation was sustained and detectable 12-24 
h after stimulation in AVICs from control and stenotic valves (Fig. 4A), thus resembling 
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data observed upon TLR3-activation (Fig. 3A). On the contrary, after TLR2 stimulation 
with Pam3CSK4, low or no activation was observed at late times (Fig. 4A). In parallel 
with NF-κB activation, a TLR4 ligand, but not a TLR2 agonist, induced the expression 
of COX-2 and ICAM-1 in AVICs from control valves and stenotic valves (Fig. 4A). 
Consistent with these results, PGE2 was detected in the supernatants of TLR4-activated 
AVICs from control and stenotic valves (Fig. 4, panels B-C). Moreover, a NF-κB 
inhibitor blocked the TLR4-mediated induction of COX-2 and ICAM-1 (Fig. 4D), the 
gene of which is known to be regulated by NF-κB [16]. Together, data demonstrate that 
TLR4 activation promotes the long-lasting and NF-κB-dependent induction of COX-2 
and ICAM-1 expression in human AVICs. 
 
3.6. TLR3 and TLR4 engagement induce a similar profile of pro-inflammatory cytokines 
in AVICs 
 
 To compare the effect of TLR ligands on the production of other pro-inflammatory 
proteins, supernatants from cells activated for 12 h with TLR agonists were incubated 
with antibody arrays (Human Cytokine Antibody Array V). In resting conditions, 
human AVICs highly express the pro-inflamatory cytokine IL-6 and to a lower extent 
the chemokines IL-8, Gro, monocyte chemoattractant protein (MCP)-1 and RANTES, 
as well as cytokines such as osteoprotegerin (OPG), TIMP1 and 2 (Fig. 5A). Notably, 
poly (I:C) activation strongly induced the expression of several pro-inflammatory 
chemokines such as Gro, Gro-α, and IL-8, and to a lower extent of chemokines such as 
RANTES, macrophage inflammatory protein (MIP)-3α, and IP-10, and cytokines such 
as IL-6, VEGF, insulin-like growth factor binding protein-2 (IGFBP2), granulocyte 
chemotactic peptide (GCP)-2, and OPG (Fig. 5B). Also, LPS activation strongly 
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induced the expression of chemokines such as Gro, Gro-α and IL-8, and to a lower 
extent of cytokines such as IL-6, VEGF and OPG (Fig. 5C). Conversely, low induction 
of OPG and epidermal growth factor (EGF) was observed after Pam3CSK4 stimulation 
(Fig. 5D), consistent with results from Fig. 4. Similar results were obtained in cells from 
diseased valves (data not shown). These results demonstrate that viral patterns can 
promote as strong pro-inflammatory phenotype as Gram-negative bacteria patterns in 
human AVICs. 
 
3.7. TLR3 and TLR4 ligands induce the activity of the calcification biomarker ALP 
 
 Since it has recently been described that LPS promotes a pro-osteogenic phenotype 
via TLR4 activation [13],
 
we tested whether a TLR3 ligand would induce ALP activity, 
a biomarker of early calcification, in human AVICs. Cells cultured with conditioning 
media showed some increase in ALP activity as compared with cells cultured in growth 
media, and LPS stimulation increased ALP activity further (Fig. 6, panels A-B), 
consistent with a previous study [13]. Strikingly, poly (I:C) increased ALP expression 
in staining experiments (Fig. 6A). Moreover, poly (I:C) significantly up-regulated ALP 
activity as compared to conditioning media (Fig. 6B), and also increased calcified 
nodule formation (data not shown). Together, these data suggest that TLR3 activation 
induces in vitro calcification of human AVICs that could be relevant to the pathogenesis 
of aortic stenosis.  
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4. Discussion 
 
 The present study demonstrates that human AVICs express most of TLRs, which are 
differentially expressed in cells from non-stenotic and stenotic valves. Moreover, cell 
exposure to viral as well as Gram-negative bacteria patterns promotes TLR-mediated 
sustained inflammatory and pro-osteogenic responses, which could be relevant to the 
pathophysiology of degenerative aortic stenosis. 
Our data is the first demonstration that human AVICs can sense viral as well as 
bacterial patterns. Our study confirms the reported expression of tlr4 and tlr2 genes in 
human AVICs [11], and also demonstrates that these cells express all tlr genes, but tlr8, 
being tlr4 the most abundant gene, followed by tlr1, tlr6 and tlr3. The gene expression 
pattern is similar in AVICs from stenotic and control valve, although a differential 
expression was observed given the increase of TLR2 and TLR4 transcript levels, as 
recently described [13], and the decrease of TLR5, and TLR9 levels in diseased valves 
as compared to control. At the protein level, our data suggest the existence of two 
populations of TLR4, being the cell-surface receptor levels lower than the ones 
internalized, in agreement with a report showing the predominant TLR4 cytosolic 
expression [11]. Even more, the total cellular TLR4 protein is higher in diseased valves, 
consistent with mRNA expression data and a recent report [13], whereas the number of 
cell-surface receptors is similar in non-stenotic and stenotic valves. A plausible 
explanation is that internalized receptors may be ready to go to the cell surface, as part 
of a recycling process that could be up-regulated in diseased valves. Alternatively, 
internalized TLR4 could exert its function through the recognition of bacterial patterns 
inside the cells.  
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Our data disclose a potential role of viral infection in the inflammatory and 
osteogenic responses underlying aortic stenosis pathogenesis, since exposure to dsRNA 
found in some viruses promotes sustained and strong TLR3-mediated pro-inflammatory 
responses as well as in vitro calcification of human AVICs. Although the role of 
infective agents in aortic stenosis has been previously suggested based on reports 
showing the presence of C. pneumoniae in valves from both early and late stages of the 
disease [1,3], the association of viral agents and the disease has not previously been 
reported. Consistent with recent reports in human AVICs [11,13], LPS from Gram-
negative bacteria promoted long-lasting pro-inflammatory responses but, in our hands, a 
lipopeptide mimicking lipoproteins from Gram-positive bacteria did not promote 
sustained responses, pointing to a specific role of Gram-negative bacteria motifs in 
promoting long-lasting inflammatory responses.
 
Strikingly, the TLR-induced pro-
inflammatory phenotype can be elicited in cells from control valves. One hypothesis to 
explain these findings would be that not a single but repeated exposure of AVICs to 
viral and/or Gram-negative bacteria infection could promote sustained inflammatory 
responses that in the long-term contribute to progressive and chronic inflammation 
underlying aortic stenosis, thus agreeing with the long-lasting clinical course of the 
disease. Although this view has not been tested experimentally, this theory would agree 
with both the induction of accumulative damage by repeated ligand challenge or with 
the induction of persistent epigenetic changes producing tissue remodelling and 
functional disturbances. 
TLR3, TLR4 and TLR2 are functionally active in AVICs from control and stenotic 
valves, as their engagement activates several TLR-mediated pro-inflammatory 
signalling pathways like NF-κB and MAPK-p38. Our data demonstrate that TLR3 and 
TLR4 ligands promote long-term activation of NF-κB, a transcription factor involved in 
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pro-inflammatory gene regulation. Results are consistent with a report demonstrating 
TLR4-mediated NF-κB activation in AVICs [11], and further demonstrate the 
involvement of NF-κB p50/p65 proteins in the TLR4-mediated induction of the 
expression of COX-2 and ICAM-1, the promoters of which contain NF-κB binding sites 
[16,17]. Consistent with a specific role of TLR4 on long-lasting inflammatory 
responses, a specific ligand for TLR2/TLR1 induced NF-κB early activation, as 
previously reported [11], but did not activate long-term responses. These findings differ 
from recent reports demonstrating TLR2-mediated release of cytokines and low 
induction of ICAM-1 in human AVICs [11,13]. This discrepancy could be explained by 
the use of different TLR2 ligands, since peptidoglycan is a non-specific TLR2 ligand 
that can also bind to NOD receptors.  
The present study is the first demonstration of a TLR-mediated induction of COX-2 
in human AVICs exposed to some pathogen patterns. These findings would support the 
potential role of COX-2 inhibitors in preventing the development or delaying the 
progression of aortic stenosis. In this respect, the negative results of a randomized trial 
testing the effects of statins on aortic stenosis progression might be related to the fact 
that the same percentage of patients in the treated and the control groups were receiving 
aspirin, [18], given that aspirin might have blocked inflammation in both groups, thus 
masking the putative protective effect of statins on stenosis progression. Our data 
suggest that TLR4-, but not TLR3-mediated induction of COX-2 is NF-κB-dependent, 
pointing out to a different transcriptional regulation. Interestingly, COX-2 induction has 
also been described in functionally related cells in other tissues, such as intestinal 
myofibroblasts [19], and it has been associated to pulmonary fibrous disorders [20].
 
Furthermore, our data show TLR4-mediated secretion of the COX-2 product, PGE2, a 
lipid mediator that could be involved in the inflammation underlying calcification of the 
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valves. In fact, PGE2 has been reported to have potential to elevate expression of VEGF 
[21], a pro-angiogenic and pro-inflammatory mediator that have been associated to 
aortic stenosis pathogenesis [1]. The production of PGE2 has also been described in 
myofibroblasts from rat lungs [22], and recent work suggests that LPS-induced PGE2 
secretion from intestinal myofibroblasts can exert paracrine effects on adjacent cells 
[19].
 
Our data demonstrate the TLR3- and TLR4-mediated induction of ICAM-1, an 
adhesion molecule typically expressed in endothelial cells. Our data agree with reports 
demonstrating TLR4-mediated ICAM-1 induction [11,23], and further show the 
involvement of NF-κB-p50 protein, a transcription factor known to regulate icam-1 
gene promoter [17]. Moreover, poly (I:C), which mimics a viral infection, strongly 
induces NF-κB-independent ICAM-1 expression in AVICs. Since poly (I:C) is known 
to induce adhesion molecules expression [24], it is important to mention that cell 
cultures were free from endothelial contaminants that could account for ICAM-1 
expression (data not shown). Furthermore, ICAM-1 might play an important role on 
myofibroblast function, since it has been described to be expressed in myofibroblast-
like cells like such as hepatic stellate cells [25]. Interestingly, in a recent multi-ethnic 
study of atherosclerosis, soluble ICAM-1 was associated with increased prevalence and 
severity of aortic valve calcification [26]. One might speculate that the source of 
sICAM-1 can not only be endothelial cells, but also TLR-activated interstitial cells. 
Consistent with the reported characteristic signalling cascades [5], TLR4 activation 
promoted NF-κB-mediated pro-inflammatory responses, and TLR3 and TLR4 also 
induced NF-κB independent responses, most likely involving the TRIF/IRF-3 route as 
suggested by TLR3- and TLR4-mediated induction of IFN-  in AVICs (data not 
shown). This is consistent with recent reports stressing the involvement of the TRIF 
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route in COX-2 induction in dendritic cells stimulated with Gram-positive bacteria [27]. 
Our data also reveal the TLR3- and TLR4-mediated activation of the MAPK/p38, a pro-
inflammatory kinase associated with both damaging and beneficial roles in the 
development of cardiovascular diseases [28]. Moreover, this kinase might be involved 
in the TLR-mediated inflammatory responses, since TLR3- and TLR4-mediated 
induction of pro-inflammatory molecules was blocked with a p38 inhibitor (data not 
shown). These findings are consistent with the reported role of p38 in the TLR4-
mediated induction of COX-2 expression in murine intestinal myofibroblasts [19].
 
Interestingly, the MAPK/ERK pathway has been associated to calcification of 
osteoblast precursors [15], and AVICs from porcine origin [29]. Our data show ERK 
basal activation, suggesting that this pathway might be over-activated in human AVICs 
and poised to contribute to a pro-osteosteogenic phenotype. However, it cannot be ruled 
out that in vitro culture conditions might artificially activate ERK and JNK pathways, 
although under the same experimental conditions the stress MAPK/p38 is not basally 
activated.  
Our data demonstrate that viral and bacterial patterns induce a strong pro-
inflammatory phenotype in human AVICs. These cells constitutively express cytokines 
such IL-6 and IL-8, as described [30], and also chemokines such as Gro, IL-8, MCP-1, 
and RANTES, and molecules involved in osteogenesis regulation, like OPG, TIMP1 
and 2. Consistent with TLR-signalling data, TLR4 engagement, but not TLR2, 
promoted the expression of several chemokines, i.e., strong induction of IL-8, as 
described [30], and also Gro and Groα, and a lower induction of MCP-1, and cytokines 
such as VEGF and OPG, known to be involved in osteogenesis regulation [2]. 
Strikingly, TLR3 activation promotes a similar cytokine profile, even induced the 
expression of more cytokines than LPS, i.e., chemokines such as RANTES, GCP-2, and 
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MIP-3α, and the cytokine IGFBP2. Altogether, these data argue in favour of an 
important role of viral patterns in the induction of a pro-inflammatory phenotype in 
human AVICs and, likely, in aortic stenosis pathogenesis. 
Interestingly, our data show for the first time that in vitro exposure of human AVIC 
to viral patterns promote a pro-osteogenic phenotype, since a TLR3 ligand induces the 
up-regulation of ALP activity, which is essential to bone mineralization, and promotes 
nodule formation (not shown). These results argue in favour of a potential role of viral 
infection in aortic stenosis pathogenesis. Furthermore, these results are reminiscent of 
data from a recent report that demonstrated TLR4 and TLR2-mediated calcific 
phenotype in human AVIC [13], and support the role of TLRs in the calcification 
process underlying aortic stenosis. 
Among the limitations of this study is the use of cultured AVICs, which might have 
changed some of their in vivo features, although it should be noted that TLR expression 
and signaling were similar in early and late passages. The study did not include analysis 
of TLR expression in patients nor in sections of valve tissue, although it should be taken 
into account that previous reports have shown TLR4 and TLR2 expression in the heart 
valve, and their increase in stenotic valves [11,13]. Further, experiments were 
performed in vitro by using agonists that artificially mimic TLR activation, and TLR-
independent effects cannot be ruled out, although it should be noted that siRNA 
experiments strongly suggest that the effects are mostly mediated by TLR (not shown).  
 
In summary, our study demonstrates that AVICs can sense a widespread range of 
bacterial and viral patterns through TLRs, which show differential expression in control 
and stenotic valve cells. Our results disclose a potential role of viral infection in the 
pathogenesis of aortic stenosis, and suggest the existence of selective pathogen-induced 
23 
 
pro-inflammatory and pro-osteogenic phenotypes in AVICs, which might be relevant to 
degenerative aortic stenosis pathogenesis. 
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Figure legends 
 
Fig. 1. Differential TLR expression in AVICs from stenotic and control valves. (A) 
Total RNA was analyzed by quantitative RT-PCR as described in Methods. Graph 
includes results obtained with AVICs from n=10 control (white bars) and stenotic 
valves (black bars). Data represent mean  SD of the relative mRNA levels normalized 
to results from the housekeeper actin. * Indicates p 0.05 when comparing data from 
control and stenotic valves. AVICs from control (B) and stenotic valves (C) were 
permeabilized with saponin or left untreated and immunolabeled with a PE-anti-human 
TLR4 antibody. Isotype control antibody results are shown in gray. Graphs are 
representative from 5 independent experiments. (D) Data represent the ratio of the 
median of mean fluorescence intensity obtained with the anti-TLR4 and the control 
antibodies and the standard deviation.  
 
Fig. 2. TLR4, TLR2, and TLR3 stimulation induces NF-κB and MAPK activation in 
AVICs from control and stenotic valves. Cells from control (A) and stenotic valves (B) 
were incubated with 1 g/ml E. coli LPS, 100 ng/ml Pam3CSK4, 10 g/ml, poly 
(I:C),10 g/ml CpG-ODN, or vehicle for the indicated times, and cells lysates were 
analyzed by Western blot with corresponding antibodies. Immunoblots are 
representative from at least 3 independent experiments. 
 
Fig. 3. TLR3 but not TLR9 activation induces NF-κB-independent expression of COX-
2, PGE2 and ICAM-1 in AVICs. (A) Cells from control and stenotic valves were 
incubated with either 10 g/ml poly (I:C) or 10 g/ml CpG-ODN or vehicle for the 
indicated times, and cells lysates were analyzed by Western blot. Immunoblots are 
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representative from 3 independent experiments. Pam indicates Pam3CSK4. (B, C) PGE2 
secretion was analyzed by ELISA in the supernatants of cells isolated from control (B) 
and stenotic valves (C), respectively. Image is representative from 2 independent 
experiments. (D) Cells were treated with 18 M NF-κB SN50 before stimulation with 
poly (I:C) or vehicle. Images correspond to different lanes of the same gel; linear 
adjustment of contrast and brightness was applied equally to all lanes. Immunoblots are 
representative from at least 3 independent experiments. 
 
Fig. 4. TLR4 but not TLR2 activation induces COX-2, PGE2 and ICAM-1 expression in 
a NF-κB-dependent manner in AVICs. (A) Cells from control and stenotic valves were 
incubated with either 1 g/ml E. coli LPS, or 100 ng/ml Pam3CSK4, or vehicle for the 
indicated times, and cells lysates were analyzed as in Fig. 3. (B, C) PGE2 secretion was 
measured in the supernatants of cells isolated from control (B) and stenotic valves (C), 
respectively. (D) Cells were treated with NF-κB SN50 before treatment with LPS or 
vehicle.  Images correspond to different lanes of the same gel; linear adjustment of 
contrast and brightness was applied equally to all lanes. 
 
Fig. 5. TLR3 activation induces a similar pro-inflammatory cytokine phenotype than 
TLR4 activation. Cells were incubated with vehicle, Poly (I:C), LPS or Pam3CSK4 for 
12 hours, and supernatants were analyzed for cytokine expression using an antibody 
array, as indicated in Material in Methods. Squares indicate positive controls, which 
were used to normalize results from different membranes. Arrows indicate 
constitutively expressed cytokines. Ovals indicate the cytokines unambiguously induced 
upon stimulation. Images are representative of two independent experiments.  
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Fig. 6. TLR3 and TLR4 activation induces alkaline phosphatase activity in human 
AVICs. Cells were treated for 17-19 days with growth media (M199) or conditioning 
media (CM) in the presence of 1 g/ml E. coli LPS, or 10 g/ml poly (I:C), or vehicle. 
(A) Cells were stained as indicated in methods. Image is representative of 3 experiments 
in duplicate. Arrows indicate areas with ALP blue staining (B) Cells were lysed and 
alkaline phosphatase activity was evaluated, as indicated in methods. Results are 
expressed as the increase fold as compared to the growth media. Data represent mean  
SD of 4 experiments in duplicate. * Indicates p 0.0001 when comparing with 
conditioning media results.  
 
